Crizotinib in sarcomatous malignancies harboring ALK fusion with a definitive partner (s): response and efficacy
J Wu, Y Hu, O Abdihamid, G Huang, S Xiao… - Frontiers in …, 2021 - frontiersin.org
Sarcoma or sarcomatoid malignancies are a set of mesenchymal-origin malignancies with
vast heterogeneity in clinical and molecular characteristics. Anaplastic lymphoma kinase …
vast heterogeneity in clinical and molecular characteristics. Anaplastic lymphoma kinase …
Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications
A Sánchez-Fdez, S Matilla-Almazán… - … & Molecular Medicine, 2023 - nature.com
Sarcomas constitute a heterogeneous group of rare and difficult-to-treat tumors that can
affect people of all ages, representing one of the most common forms of cancer in childhood …
affect people of all ages, representing one of the most common forms of cancer in childhood …
ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights
M Jung, KC Moon, J Bae, TM Kim… - … of Pathology & …, 2022 - meridian.allenpress.com
Context.—A wide spectrum of mesenchymal tumors harboring ALK gene rearrangements
has been identified outside the archetypal example of ALK-positive inflammatory …
has been identified outside the archetypal example of ALK-positive inflammatory …
Synchronous lung and multiple soft tissue metastases developed from osteosarcoma of tibia: a rare case report and genetic profile analysis
C Zheng, Y Wang, Y Luo, Z Pang, Y Zhou… - BMC Musculoskeletal …, 2022 - Springer
Background Osteosarcoma is the most common primary malignant bone tumor with a highly
metastatic propensity in children and young adolescents. The majority of metastases …
metastatic propensity in children and young adolescents. The majority of metastases …
Cutaneous inflammatory myofibroblastic tumor with CARS‐ALK fusion: Case report and literature review
KJ McCollum, G Jour… - Journal of Cutaneous …, 2022 - Wiley Online Library
Cutaneous inflammatory myofibroblastic tumors (IMT) constitute a rare entity, generating a
diagnostic pitfall when diagnosing spindle cell proliferation within the dermis. Raising …
diagnostic pitfall when diagnosing spindle cell proliferation within the dermis. Raising …
CORR Insights®: Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based …
S Iwata - Clinical Orthopaedics and Related Research®, 2022 - journals.lww.com
Sarcomas are rare and diverse. They include about 50 different histologic subtypes of
malignancy, according to the latest WHO classification [12], each of which exhibits unique …
malignancy, according to the latest WHO classification [12], each of which exhibits unique …
New insights in the immuno-and molecular biology of soft tissue and bone tumors with therapeutic implications
V Siozopoulou - 2021 - repository.uantwerpen.be
Soft tissue tumor and tumors of the bone are rare neoplasm's. The sarcoma account for less
than 1% while bone sarcoma only for 0.2% of all malignant tumors. Nowadays, surgery …
than 1% while bone sarcoma only for 0.2% of all malignant tumors. Nowadays, surgery …